review Open AccessTop 1% cited
p53 mutations in cancer
Nature Cell Biology · 2012 · Vol. 15(1) · pp. 2–8
Patricia Müller✉Karen H. Vousden(Cancer Research UK Scotland Institute)
Cancer-related Molecular PathwaysEpigenetics and DNA MethylationRNA modifications and cancerMutantBiologyP53 proteinGain of functionCell biologyCancerMutationFunction (biology)Loss functionCancer cell
MeSH terms
AnimalsHumansMutationNeoplasmsProtein BindingProtein Processing, Post-TranslationalTranscription FactorsSignal TransductionGene Expression Regulation, NeoplasticTumor Suppressor Protein p53Tumor Suppressor ProteinsMutant ProteinsMolecular Targeted Therapy
Citations
1,628
FWCI
50.35
field-weighted impact
References
102
Percentile
100%
vs. same field & year
Citations per year
Cited by
The role of p53 in cancer drug resistance and targeted chemotherapy
Oncotarget · 2016 · 570 citations
<i>TP53</i> Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response
Journal of Cellular Biochemistry · 2016 · 348 citations
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Cancer Cell · 2014 · 1,533 citations
Targeting Oncogenic Mutant p53 for Cancer Therapy
Frontiers in Oncology · 2015 · 333 citations
The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity
Cell Reports · 2017 · 920 citations
The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism
Cancer Letters · 2014 · 790 citations
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas
Cell Reports · 2019 · 758 citations
Mitochondrial Dysfunction in Cancer
Frontiers in Oncology · 2013 · 509 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.